Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Method for localizing and calculating vaginal dose in brachytherapy

Y Maruyama, J R Van Nagell, A Martin

    Radiology
    |August 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Use of compounds naturally labeled with stable isotopes for the study of the metabolism of glycoprotein neutral sugars by gas-liquid chromatography-isotope-ratio mass spectrometry. Technical validation in the rat.

    Carbohydrate research·1992
    Same author

    Potent gp120-like neurotoxic activity in the cerebrospinal fluid of HIV-infected individuals is blocked by peptide T.

    Brain research·1992
    Same author

    Lateralized mediation of arousal and habituation: differential bilateral electrodermal activity in unilateral temporal lobectomy patients.

    Neuropsychologia·1992
    Same author

    Transfusion-associated graft-versus-host disease, monoclonal gammopathy and PCR.

    British journal of haematology·1992
    Same author

    What do patients want to know about their inflammatory bowel disease?

    The Italian journal of gastroenterology·1992
    Same author

    Phosphatidate phosphohydrolases in liver, heart and adipose tissue of the JCR:LA corpulent rat and the lean genotypes: implications for glycerolipid synthesis and signal transduction.

    International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity·1992
    Same journal

    Erratum for: Prediction of Lobar Emphysema Progression with a CT-Based Foundational Model.

    Radiology·2026
    Same journal

    Erratum for: Associations of MRI-derived Paraspinal IMAT and LMM with Cardiometabolic Risk Factors: Results from a German Cohort.

    Radiology·2026
    Same journal

    Erratum for: Blue Rubber Bleb Nevus Syndrome.

    Radiology·2026
    Same journal

    Redefining the Clinical Role of MRI in Endometrial Cancer Staging.

    Radiology·2026
    Same journal

    To Ablate or Not to Ablate: The Colorectal Liver Metastasis Question.

    Radiology·2026
    Same journal

    The Limits of Radiologic Categorization in Pulmonary Nonsolid Nodules.

    Radiology·2026
    See all related articles

    New vaginal reference dose points (VR, VL, VA, VP) improve radiation therapy planning by ensuring accurate dose delivery to critical vaginal tumor volumes and reducing central pelvic recurrence risk.

    Area of Science:

    • Radiotherapy
    • Medical Physics
    • Gynecologic Oncology

    Background:

    • Computerized treatment planning in radiotherapy allows for more precise dose assessment.
    • Accurate dose delivery to vaginal surfaces is crucial for effective treatment and minimizing recurrence.
    • Traditional methods struggle with dose prescription to critical tumor volumes within the vagina.

    Observation:

    • Contrast agents are used to visualize vaginal surfaces relative to applicators during radiotherapy.
    • Vaginal reference dose points (VR, VL, VA, VP) are proposed for standardized dose specification.
    • Standard loaded implant configurations show higher doses at VR/VL compared to VA/VP.

    Findings:

    • Proposed vaginal reference dose points (VR, VL, VA, VP) enable precise dose assessment at critical vaginal sites.

    Related Experiment Videos

  • Dose specification at these points helps avoid underdosing caused by suboptimal applicator geometry.
  • Focusing on central vaginal doses can decrease the likelihood of central pelvic recurrence.

    • Implications:

    • Implementation of VR, VL, VA, and VP points can optimize radiation dose distribution in vaginal brachytherapy.
    • This approach enhances treatment efficacy for gynecologic cancers by ensuring adequate tumor coverage.
    • Standardized dose points improve consistency and reproducibility in radiotherapy planning and delivery.